Evidence-based standards for the safe insertion, management, medication administration, and complication prevention of neuraxial access devices including epidural and intrathecal catheters, implanted neuraxial ports, and intrathecal drug delivery (ITDD) systems across acute care, outpatient, and home care settings.
Establishes requirements for the appropriate selection, use, configuration, labeling, and replacement of primary and secondary administration sets for all infusion types, including standard solutions, parenteral nutrition, lipids, blood products, propofol, and hemodynamic monitoring systems.
Clinical practice guideline establishing standards for safe and effective implementation of patient-controlled analgesia across healthcare settings, including pharmacologic agents, routes of administration, monitoring requirements, and authorized agent-controlled analgesia protocols.
Evidence-based clinical guidelines for safe parenteral nutrition administration covering vascular access selection, peripheral PN, filtration requirements, administration set management, infection prevention, patient monitoring, light protection for premature infants, and patient education.
Evidence-based standards for safe administration of infusion medications and solutions, covering verification requirements, clinical appropriateness review, technology integration including barcode scanning and smart pump use, vascular access patency assessment, first-dose protocols, and adverse event reporting.
Evidence-based standards for safe compounding and preparation of parenteral solutions and medications, covering sterile technique, pharmacy-based preparation, vial and ampoule handling, labeling requirements, and competency requirements for all clinicians involved in medication preparation.
Evidence-based standards for safe preparation, handling, and administration of antineoplastic medications including prescribing authorization, occupational safety and PPE requirements, closed system drug transfer devices, spill management, vesicant administration, and adverse reaction protocols.
Evidence-based standards for safe administration of biologic therapies including colony-stimulating factors, monoclonal antibodies, immunoglobulins, and gene therapies. Covers patient assessment, care setting selection, biosimilar considerations, REMS compliance, subcutaneous immunoglobulin administration, and adverse reaction management.
Establishes standards and requirements for flushing and locking all vascular access devices to maintain catheter patency, prevent occlusion, reduce catheter-associated bloodstream infection risk, and ensure safe medication delivery across all device types and patient populations.
Standards of practice for the prevention, recognition, and management of infiltration and extravasation from peripheral and central vascular access devices, including antidote protocols.